Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Case Studies: Renal Cell Cancer
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
Frontline TKI in Intermediate-Risk Renal Cell Carcinoma
Perspective on the Treatment of Advanced Renal Cell Cancer
Treatment of Refractory Metastatic Renal Cell Carcinoma
Therapeutic Approach for Metastatic Renal Cell Carcinoma
Intermediate-Risk Newly Diagnosed Metastatic Renal Cell Carcinoma
Metastatic RCC, Progressing on Multiple Therapies
Choosing Second-Line Therapy for Metastatic Kidney Cancer
JTT Articles
Participating Practices Commend CMS for OCM Changes
The Role of Liquid Biopsy in NSCLC Continues to Emerge
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
>> View Peer-Reviewed Articles
Most Popular
FDA Grants Accelerated Approval to Tazemetostat for Patients With Epithelioid Sarcoma
FDA Grants AMG 510 Fast Track Designation for KRAS G12C+ NSCLC
Neoadjuvant Systemic Therapy Improves Eligibility for Breast-Conserving Surgery in TNBC
Study Solidifies Confidence in Liquid Biopsies for Faster Biomarker Detection in NSCLC, Expert Says
Publications
